NCT03340220View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.

PHASE1CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

November 13, 2017

Primary Completion Date

November 26, 2021

Study Completion Date

November 26, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

XPF-008

Capsule filled with XEN1101

DRUG

Microcrystalline Cellulose

Placebo capsule

DRUG

XPF-010

Capsule filled with XEN1101

DRUG

Itraconazole 400mg

Oral

Trial Locations (1)

SE1 1YR

Richmond Pharmacology Ltd., London

All Listed Sponsors

lead

Xenon Pharmaceuticals Inc.

INDUSTRY

NCT03340220 - Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101. | Biotech Hunter | Biotech Hunter